Early Stage Enterprises
6
6M
3
0.24
0.50
2
- Stages of investment
- Areas of investment
Summary
In 1996 was created Early Stage Enterprises, which is appeared as VC. The main office of represented VC is situated in the Princeton. The fund was located in North America if to be more exact in United States.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Early Stage Enterprises, startups are often financed by Maryland Department of Business and Economic Development, Thomas Weisel Venture Partners, Kodiak Venture Partners. The meaningful sponsors for the fund in investment in the same round are Maryland Department of Business and Economic Development, Thomas Weisel Venture Partners, Kodiak Venture Partners. In the next rounds fund is usually obtained by Maryland Department of Business and Economic Development, Thomas Weisel Venture Partners, Roche Venture Fund.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Software. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Highway To Health, Application Security, Viracor-IBT Laboratories.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The higher amount of exits for fund were in 2014. The fund is constantly included in less than 2 investment rounds annually. This Early Stage Enterprises works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2004.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.24
- Follow on index
- 0.50
- Investments by industry
- Health Care (4)
- Life Science (3)
- Medical (3)
- Information Technology (3)
- Health Diagnostics (3) Show 6 more
- Investments by region
-
- United States (6)
- Peak activity year
- 2004
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 85M
- Group Appearance index
- 1.00
- Avg. company exit year
- 13
- Avg. multiplicator
- 5.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Viracor-IBT Laboratories | 20 Jul 2004 | Biotechnology, Information Technology, Health Care, Health Diagnostics, Medical, Life Science | Early Stage Venture | 3M | United States, Missouri, Lee's Summit |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.